Clarkston Capital Partners, LLC Pfizer Inc Transaction History

Clarkston Capital Partners, LLC

$5.41 Billion
Q3 2024

A detailed history of Clarkston Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clarkston Capital Partners, LLC holds 57,777 shares of PFE stock, worth $1.54 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

57,777

Previous 44,077 31.08%

Holding current value

$1.54 Million

Previous $1.23 Million 35.6%

% of portfolio

0.03%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $379,490 - $430,043	13,700 Added 31.08%	57,777 $1.67 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $146,053 - $171,147	-5,782 Reduced 11.6%	44,077 $1.23 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $681,993 - $885,833	-26,100 Reduced 34.36%	49,859 $1.44 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $19,254 - $22,506	-600 Reduced 0.78%	75,959 $2.52 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $33,591 - $38,864	-930 Reduced 1.2%	76,559 $2.81 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $86,145 - $112,149	-2,187 Reduced 2.74%	77,489 $3.16 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $17,869 - $23,326	428 Added 0.54%	79,676 $4.08 Million
Q3 2022 Nov 16, 2022	BUY	$43.76 - $53.42 $48,136 - $58,762	1,100 Added 1.41%	79,248 $3.47 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $2,373 - $2,813	-51 Reduced 0.07%	78,148 $4.1 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $4,026 - $4,988	-88 Reduced 0.11%	78,199 $4.05 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.66 Million - $2.46 Million	40,139 Added 105.22%	78,287 $4.62 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $5,063 - $6,504	129 Added 0.34%	38,148 $1.64 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $175,061 - $198,315	-4,875 Reduced 11.37%	38,019 $1.49 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $1.23 Million - $1.39 Million	36,739 Added 596.9%	42,894 $1.55 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $49,996 - $56,135	-1,352 Reduced 18.01%	6,155 $0
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $10.9 Million - $11.9 Million	-289,538 Reduced 97.47%	7,507 $0
Q4 2018 Jan 17, 2019	SELL	$38.47 - $43.86 $129,259 - $147,369	-3,360 Reduced 1.12%	297,045 $12.3 Million
Q3 2018 Oct 18, 2018	BUY	$34.47 - $41.81 $22,922 - $27,803	665 Added 0.22%	300,405 $13.2 Million
Q2 2018 Jul 19, 2018	SELL	$32.98 - $35.16 $74,864 - $79,813	-2,270 Reduced 0.75%	299,740 $10.9 Million
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $199,437 - $231,375	6,250 Added 2.11%	302,010 $10.7 Million
Q4 2017 Jan 22, 2018	BUY	$33.26 - $35.29 $245,458 - $260,440	7,380 Added 2.56%	295,760 $10.7 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $8.94 Million - $9.85 Million	288,380	288,380 $10.3 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarkston Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarkston Capital Partners, LLC with notifications on news.

Account

Clarkston Capital Partners, LLC Pfizer Inc Transaction History